<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-ramipril.xml</id>
  <title>Recalls Watch: Ramipril</title>
  <link rel="self" href="https://recalls.watch/feed/substance-ramipril.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-09-02T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99711/</id>
    <title>Hikma Pharmaceuticals USA INC.: Ramipril Capsules USP</title>
    <link href="https://recalls.watch/recall/fda/99711/"/>
    <updated>2026-09-02T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95610/</id>
    <title>Lupin Pharmaceuticals Inc.: Ramipril Capsules USP 2.5 mg and 2 more</title>
    <link href="https://recalls.watch/recall/fda/95610/"/>
    <updated>2024-11-27T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor</summary>
  </entry>
</feed>
